Paying for cost-effective health care: Does it violate both static- and dynamic efficiency?
Recent research has questioned the rationales of using cost-effectiveness metrics of medical technologies to guide reimbursement. I discuss here the underlying ideas of this research, which argues that reimbursement based on cost effectiveness criteria leads to both static- and dynamic inefficiencies.
pharmaceuticals, reimbursement, cost-effectiveness analysis
This work is licensed under a Creative Commons Attribution 3.0 License.